Clear cell chondrosarcoma in Von Hippel-Lindau disease

Dreijerink, K. M. A., van Leeuwaarde, R. S., Hackeng, W. M., Giles, R. H., de Leng, W. W. J., Jutte, P. C., Suurmeijer, A. J. H., van Nesselrooij, B. P. M. & Brosens, L. A. A., 31-Oct-2019, In : Familial Cancer. 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

  • Koen M. A. Dreijerink
  • Rachel S. van Leeuwaarde
  • Wenzel M. Hackeng
  • Rachel H. Giles
  • Wendy W. J. de Leng
  • Paul C. Jutte
  • Albert J. H. Suurmeijer
  • Bernadette P. M. van Nesselrooij
  • Lodewijk A. A. Brosens

A diagnosis of clear cell chondrosarcoma of the ulna was made in a patient with Von Hippel-Lindau disease (VHL). After surgery, genetic analysis of the tumor tissue showed loss of heterozygosity at the VHL gene locus. Immunohistochemical analysis confirmed loss of expression of the VHL protein in the tumor cells. In addition, abundant Cyclin D1 expression in the tumor was observed. Chondrosarcoma has been described before in a VHL patient and VHL protein expression has been correlated to tumor grade in a series of sporadic chondrosarcomas. In this report, we show that clear cell chondrosarcoma may be a rare but canonical VHL manifestation through a cell-autonomous mechanism involving somatic loss-of-heterozygosity of the VHL tumor suppressor gene. We discuss the relevance of this observation with regard to the pathogenesis of clear cell chondrosarcoma in the context of VHL.

Original languageEnglish
Number of pages5
JournalFamilial Cancer
Publication statusPublished - 31-Oct-2019


  • Clear cell chondrosarcoma, Von Hippel-Lindau disease, VHL gene, Cyclin D1

View graph of relations

ID: 108157938